Current role
CEO, Board Member, CFO, Chief Accounting Officer
2025-04-09–present
Jon P. Stonehouse
Board Member
Biocryst Pharmaceuticals Inc (BCRX)Chief Accounting Officer
Biocryst Pharmaceuticals Inc (BCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jon P. Stonehouse
Jon P. Stonehouse is recorded as CEO, Board Member, CFO and Chief Accounting Officer at Biocryst Pharmaceuticals Inc (BCRX). Biocryst Pharmaceuticals Inc reported in an 8-K filed June 12, 2026 that Jon P. Stonehouse was appointed director, effective June 11, 2026. Biocryst Pharmaceuticals Inc reported in an 8-K filed April 10, 2025 that Jon P. Stonehouse was appointed Interim Chief Financial Officer and Interim Principal Accounting Officer, effective April 9, 2025. Biocryst Pharmaceuticals Inc reported in an 8-K filed April 10, 2025 that Jon P. Stonehouse was appointed Interim Principal Accounting Officer, effective April 9, 2025. Equibles holds 4 filed executive changes naming Jon P. Stonehouse; each is listed under recent activity with its source filing. The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $12,951,082 for Jon P. Stonehouse in fiscal 2025, including a base salary of $728,466. Disclosed compensation is on record for 9 fiscal years.
“| Jon P. Stonehouse | 173,944,412 | 9,911,054 |”
“On April 7, 2025, the Board appointed Jon P. Stonehouse, the Company’s Chief Executive Officer, to serve as Interim Chief Financial Officer and Interim Principal Accounting Officer, effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-11–present
-
Current
2025-04-09–present
-
Current
2025-04-09–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biocryst Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Charles Gayer CEO, Board Member
- Charlie Gayer CEO, Board Member
- Vincent J. Milano Chairman, Board Member
- Anthony Doyle CFO
- Babar Ghias CFO, Chief Accounting Officer
- Thomas R. Staab II CFO
- A. Machelle Sanders Board Member
- Alan G. Levin Board Member
- Amy E. McKee Board Member
- Amy E. McKee, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biocryst Pharmaceuticals Inc (BCRX) | Former President and Chief Executive Officer | $728,466 | $12,951,082 |
| 2024 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $705,536 | $8,317,286 |
| 2023 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $665,600 | $4,777,778 |
| 2022 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $640,000 | $6,982,994 |
| 2021 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $583,495 | $7,061,225 |
| 2020 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $566,500 | $6,034,941 |
| 2019 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $550,000 | $2,284,297 |
| 2018 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $550,000 | $4,167,643 |
| 2017 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $532,823 | $3,921,189 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.